By David Bautz, PhD NASDAQ:MTVA READ THE FULL MTVA RESEARCH REPORT Business Update Positive Results for 8-week 48 mg Cohort ...
Cohort 4 data demonstrated positive safety and efficacy results, including additional clinical benefit observed following ...
Niigata, Japan - A new Japanese study reveals significant birth cohort effects on the incidence trend of ESKD requiring RRT. “Different birth cohorts may have different levels of exposure to a ...
By Tarun Sai Lomte A nationwide Swedish study reveals that when HPV vaccination reaches high coverage through schools, it ...